Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01767415 · ClinicalTrials.gov registry record · Phase 1
Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection
A Phase 1 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT01767415 is a Phase 1 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 10 participants.
The verdict
NCT01767415, a Phase 1 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate whether stereotactic indigo carmine injection can safely increase the extent of tumor resection.
Interventions
- DRUG Indigo carmine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-04 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01767415
The ClinicalTrials.gov registry entry for NCT01767415 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Indigo carmine is the first listed.
NCT01767415 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01767415 about?
NCT01767415 is a clinical study titled "Intra-operative Use of Indigo Carmine Dye for the Delineation of Ill Defined Tumor Borders Using Stereotactic Injection". The purpose of this study is to investigate whether stereotactic indigo carmine injection can safely increase the extent of tumor resection.
What is the current status of trial NCT01767415?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2012-04. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01767415?
The interventions under investigation include: Indigo carmine (DRUG).
Who is sponsoring clinical trial NCT01767415?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.